床旁超声与常规妊娠晚期超声对未诊断臀先露及围产期结局的影响:一项观察性多中心队列研究
该回顾性多中心队列研究比较了常规妊娠晚期超声或床旁超声(POCUS)与标准产前保健对足月臀先露未诊断比例及围产期结局的影响。结果显示,实施普遍超声筛查后未诊断臀先露比例显著降低(圣乔治医院从14.2%降至2.8%,诺福克与诺里奇大学医院从16.2%降至3.5%,均p<0.001),贝叶斯回归显示未诊断臀先露率降低71%(RR 0.29,95%CrI 0.20-0.38),5分钟Apgar评分<7分率降低77%(RR 0.23,95%CrI 0.14-0.38)。作者认为研究结果支持妊娠晚期超声筛查胎先露的政策。
要点
- 实施普遍妊娠晚期超声或床旁超声筛查后,未诊断足月臀先露比例显著降低。
- 贝叶斯回归显示未诊断臀先露率降低71%(RR 0.29,95%CrI 0.20-0.38)。
- 臀先露妊娠中5分钟Apgar评分<7分率降低77%(RR 0.23,95%CrI 0.14-0.38)。
核心结论
- 研究发现常规机构妊娠晚期超声或床旁超声政策均与未诊断足月臀先露比例降低及新生儿结局改善相关。
- 研究结果支持妊娠晚期超声筛查胎先露的政策。
- 未来研究应关注床旁超声用于胎先露的成本效益。
研究设计与样本
- 回顾性多中心队列研究,纳入圣乔治医院(SGH)与诺福克与诺里奇大学医院(NNUH)的数据。
- 妊娠根据接受常规妊娠晚期扫描(SGH)或床旁超声(NNUH)分组。
- 排除多胎妊娠、37周前早产、先天异常及因臀先露行计划剖宫产的孕妇。
- 采用贝叶斯方法,使用先前类似研究的信息性先验更新估计值。
- 使用贝叶斯对数二项回归模型分析未诊断臀先露与不良围产期结局的关联。
主要发现
- SGH实施普遍筛查前(2016年至2020年)足月臀先露未诊断比例为14.2%(82/578),实施后(2020年至2021年)为2.8%(7/251),p<0.001。
- NNUH实施普遍床旁超声筛查前(2015年)足月臀先露未诊断比例为16.2%(27/167),实施后(2020年至2021年)为3.5%(5/142),p<0.001。
- 贝叶斯回归显示普遍超声实施后未诊断臀先露率降低71%(RR 0.29,95%CrI 0.20-0.38),后验概率大于99.9%。
- 臀先露妊娠中5分钟Apgar评分<7分率降低77%(RR 0.23,95%CrI 0.14-0.38),后验概率大于99.9%。
- 缺氧缺血性脑病(HIE)降低的后验概率为89.5%(RR 0.32,95%CrI 0.05-1.77),扩展围产期死亡率降低的后验概率为85.1%(RR 0.21,95%CrI 0.01-3.00)。
关键数值与推荐
- 未诊断臀先露定义:(a)足月临产或胎膜已破就诊的妇女随后发现臀先露;(b)足月引产就诊时在引产前发现臀先露。
- 主要结局为所有足月臀先露中未诊断的比例。
- 次要结局包括分娩方式、出生时孕龄、出生体重、急诊剖宫产发生率及新生儿不良结局。
临床怎么用
- 研究支持妊娠晚期超声筛查胎先露的政策。
- 作者建议未来研究应关注床旁超声用于胎先露的成本效益。
局限性
- 研究缺乏研究期间通过标准产前转诊途径进行的机构超声扫描次数或外倒转术(ECV)的可靠数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate knowledge of fetal presentation at term is vital for optimal antenatal and intrapartum care. The primary objective was to compare the impact of routine third trimester ultrasound or point-of-care ultrasound (POCUS) with standard antenatal care, on the incidence of overall and proportion of all term breech presentations that were undiagnosed at term, and on the related adverse perinatal outcomes. METHODS AND FINDINGS: This was a retrospective multicentre cohort study where we included data from St. George's (SGH) and Norfolk and Norwich University Hospitals (NNUH). Pregnancies were grouped according to whether they received routine third trimester scan (SGH) or POCUS (NNUH). Women with multiple pregnancy, preterm birth prior to 37 weeks, congenital abnormality, and those undergoing planned cesarean section for breech presentation were excluded. Undiagnosed breech presentation was defined as follows: (a) women presenting in labour or with ruptured membranes at term subsequently discovered to have a breech presentation; and (b) women attending for induction of labour at term found to have a breech presentation before induction. The primary outcome was the proportion of all term breech presentations that were undiagnosed. The secondary outcomes included mode of birth, gestational age at birth, birth weight, incidence of emergency cesarean section, and the following neonatal adverse outcomes: Apgar score <7 at 5 minutes, unexpected neonatal unit (NNU) admission, hypoxic ischemic encephalopathy (HIE), and perinatal mortality (including stillbirths and early neonatal deaths). We employed a Bayesian approach using informative priors from a previous similar study; updating their estimates (prior) with our own data (likelihood). The association of undiagnosed breech presentation at birth with adverse perinatal outcomes was analyzed with Bayesian log-binomial regression models. All analyses were conducted using R for Statistical Software (v.4.2.0). Before and after the implementation of routine third trimester scan or POCUS, there were 16,777 and 7,351 births in SGH and 5,119 and 4,575 in NNUH, respectively. The rate of breech presentation in labour was consistent across all groups (3% to 4%). In the SGH cohort, the percentage of all term breech presentations that were undiagnosed was 14.2% (82/578) before (years 2016 to 2020) and 2.8% (7/251) after (year 2020 to 2021) the implementation of universal screening (p < 0.001). Similarly, in the NNUH cohort, the percentage of all term breech presentations that were undiagnosed was 16.2% (27/167) before (year 2015) and 3.5% (5/142) after (year 2020 to 2021) the implementation of universal POCUS screening (p < 0.001). Bayesian regression analysis with informative priors showed that the rate of undiagnosed breech was 71% lower after the implementation of universal ultrasound (RR, 0.29; 95% CrI 0.20, 0.38) with a posterior probability greater than 99.9%. Among the pregnancies with breech presentation, there was also a very high probability (>99.9%) of reduced rate of low Apgar score (<7) at 5 minutes by 77% (RR, 0.23; 95% CrI 0.14, 0.38). There was moderate to high probability (posterior probability: 89.5% and 85.1%, respectively) of a reduction of HIE (RR, 0.32; 95% CrI 0.0.05, 1.77) and extended perinatal mortality rates (RR, 0.21; 95% CrI 0.01, 3.00). Using informative priors, the proportion of all term breech presentations that were undiagnosed was 69% lower after the initiation of universal POCUS (RR, 0.31; 95% CrI 0.21, 0.45) with a posterior probability greater of 99.9%. There was also a very high probability (99.5%) of a reduced rate of low Apgar score (<7) at 5 minutes by 40% (RR, 0.60; 95% CrI 0.39, 0.88). We do not have reliable data on number of facility-based ultrasound scans via the standard antenatal referral pathway or external cephalic versions (ECVs) performed during the study period. CONCLUSIONS: In our study, we observed that both a policy of routine facility-based third trimester ultrasound or POCUS are associated with a reduction in the proportion of term breech presentations that were undiagnosed, with an improvement in neonatal outcomes. The findings from our study support the policy of third trimester ultrasound scan for fetal presentation. Future studies should focus on exploring the cost-effectiveness of POCUS for fetal presentation.
引用
- Knights S, Prasad S, Kalafat E, et al. Impact of point-of-care ultrasound and routine third trimester ultrasound on undiagnosed breech presentation and perinatal outcomes: An observational multicentre cohort study. PLoS Med. 2023. PMID: 37023211. doi:10.1371/journal.pmed.1004192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。